Results 181 to 190 of about 264,698 (302)

Correction to "Ephedrine for Reducing Onset Time of Rocuronium in Elderly Patients: A Randomised Study". [PDF]

Acta Anaesthesiol Scand
europepmc   +1 more source

NT-proBNP levels and arrhythmias in adolescents with chronic upper gastrointestinal diseases. [PDF]

Rev Paul Pediatr
Shevchenko N, Krutenko N, Zimnytska T, Voloshyn K, Holovko T.   +4 more
europepmc   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Malignant Early Repolarization Syndrome Unmasked by Acute Respiratory Distress Syndrome in a Young Adult. [PDF]

JACC Case Rep
Sah S, Doshi P, Bhandari J, Chapagain H, Pillai N.   +4 more
europepmc   +1 more source

Driving and arrhythmias

BMJ, 2002
Helen, Binns, John, Camm
openaire   +3 more sources

Prevalence of transthyretin cardiac amyloidosis in undifferentiated heart failure with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 1176-1182, April 2025.
Abstract Aims Transthyretin amyloid cardiomyopathy (ATTR‐CM) is an increasinglyrecognized cause of heart failure with preserved ejection fraction (HFpEF), which may be diagnosed non‐invasively using 99mTc 3,3‐diphosphono‐1,2‐propanodicarboxylic acid (DPD) scintigraphy‐based diagnostic criteria.
L. Healy, G. Giblin, A. Gray, N. Starr, L. Murphy, D. O'Sullivan, E. Kavanagh, C. Howley, C. Tracey, E. Morrin, A. McDaid, A. Clarke, J.O. O'Neill, E. Joyce, M. O'Connell, N. G. Mahon   +15 more
wiley   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Extended Wearable ECG Monitoring Detects Unrecognised Arrhythmias After COPD Exacerbation: The PRECURSOR Pilot Study. [PDF]

Clin Respir J
Kotsiou OS, Gogou E, Siachpazidou D, Pinaka M, Bardaka F, Garyfallos A, Mantzaris D, Garyfallos A, Konstantinidis A, Gourgoulianis KI.   +9 more
europepmc   +1 more source

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

ESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri, Ahmad Gharaibeh, Lubika Nkashama, Abdelrahman Abushouk, Osama Abushawer, Amir Mehdizadeh‐Shrifi, Bianca Honnekeri, Cassandra Calabrese, Venu Menon, Pauline Funchain, Patrick Collier, Diego Sadler, Rohit Moudgil   +12 more
wiley   +1 more source

Rapid and sustained clinical improvement after coronary sinus reducer implantation at the level of the Vieussens valve

Cardiology Journal
Tomasz Górnik, Konrad Masiarek, Włodzimierz Grabowicz, Jakub Pitura, Felix Woitek, Michał Plewka   +5 more
doaj   +1 more source